This inventor holds 1 USPTO granted patent. Top assignee: Sun Yat-Senuniversity. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jialuo Huang: Innovator in Prostate Cancer Treatment
Introduction
Jialuo Huang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of cancer research, particularly in developing treatments for prostate cancer. His innovative work has the potential to change the landscape of cancer therapies.
Latest Patents
Jialuo Huang holds a patent for a daphnane diterpenoid resistant to prostate cancer and its preparation method. This invention relates to a daphnane diterpenoid compound that significantly inhibits the proliferation of various prostate cancer cells. The activities of some of these compounds at both cellular and animal levels surpass those of the existing clinical targeting drug enzalutamide. Furthermore, the daphnane diterpenoid compounds exhibit strong synergistic effects when used in combination with enzalutamide, positioning them as promising candidates for the treatment or adjuvant treatment of castration-resistant prostate cancer. He has 1 patent to his name.
Career Highlights
Jialuo Huang is affiliated with Sun Yat-sen University, where he conducts his research and development work. His dedication to advancing cancer treatment has garnered attention in the scientific community.
Collaborations
He collaborates with esteemed colleagues such as Sheng Yin and Xuelong Yan, contributing to a dynamic research environment focused on innovative cancer therapies.
Conclusion
Jialuo Huang's work in developing a daphnane diterpenoid for prostate cancer treatment exemplifies the impact of innovative research in medicine. His contributions are paving the way for new therapeutic options in the fight against cancer.